Chronic kidney disease and premature ageing of the adaptive immune response

Current Urology Reports

Volumn 16, Issue 1, 2015, Pages 1-7

  Betjes, Michiel G H ^a   Litjens, Nicolle H R ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Ageing; End stage renal disease; Immune system; Inflammation; Oxidative stress; Uremia

Indexed keywords

ADAPTIVE IMMUNITY; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL AGING; CELL FUNCTION; CELL POPULATION; CELLULAR IMMUNITY; CHRONIC KIDNEY DISEASE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DENDRITIC CELL; DISEASE ASSOCIATION; END STAGE RENAL DISEASE; EPIGENETICS; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; INFLAMMATION; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LATENT PERIOD; LYMPHOID CELL; MEMORY T LYMPHOCYTE; NONHUMAN; OXIDATIVE STRESS; PREMATURE IMMUNOLOGICAL AGING; PREMATURITY; T LYMPHOCYTE; TELOMERE; THYMUS FUNCTION; UREMIA; CHRONIC KIDNEY FAILURE; GENETIC EPIGENESIS; GENETICS; IMMUNOLOGY; LYMPHOCYTE; METABOLISM; PREMATURE AGING;

ADAPTIVE IMMUNITY; AGING, PREMATURE; CELL AGING; CYTOMEGALOVIRUS INFECTIONS; EPIGENESIS, GENETIC; HUMANS; IMMUNITY, CELLULAR; KIDNEY FAILURE, CHRONIC; LYMPHOCYTES; RENAL INSUFFICIENCY, CHRONIC; TELOMERE; UREMIA;

EID: 84919902835     PISSN: 15272737     EISSN: 15346285     Source Type: Journal    
DOI: 10.1007/s11934-014-0471-9     Document Type: Article

References (40)

1. Verkade MA, van de Wetering J, Klepper M, Vaessen LM, Weimar W, Betjes MG. Peripheral blood dendritic cells and GM-CSF as an adjuvant for hepatitis B vaccination in hemodialysis patients. Kidney Int. 2004;66:614–21.
2. Stewart JH, Vajdic CM, van Leeuwen MT, et al. The pattern of excess cancer in dialysis and transplantation. Nephrol Dial Transplant. 2009;24:3225–31.
3. Meier P, Golshayan D, Blanc E, Pascual M, Burnier M. Oxidized LDL modulates apoptosis of regulatory T cells in patients with ESRD. J Am Soc Nephrol. 2009;20:1368–84.
4. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. The New England journal of medicine. 2004;351:1296–305.
5. Betjes MG, Langerak AW, van der Spek A, de Wit EA, Litjens NH. Premature aging of circulating T cells in patients with end-stage renal disease. Kidney Int. 2011;80:208–17. This study demonstrates significant premature immunological ageing of the T cell system in ESRD patients based on assesment of thymic function, telomere length and T cell differentiation.
6. Litjens NH, de Wit EA, Betjes MG. Differential effects of age, cytomegalovirus-seropositivity and end-stage renal disease (ESRD) on circulating T lymphocyte subsets. Immun Ageing. 2011;8:2.
7. Meijers RW, Litjens NH, de Wit EA, et al. Cytomegalovirus contributes partly to uraemia-associated premature immunological ageing of the T cell compartment. Clin Exp Immunol. 2013;174:424–32.
8. Steinman RM, Idoyaga J. Features of the dendritic cell lineage. Immunol Rev. 2010;234:5–17.
9. Litjens NH, van Druningen CJ, Betjes MG. Progressive loss of renal function is associated with activation and depletion of naive T lymphocytes. Clin Immunol. 2006;118:83–91.
10. Yoon JW, Gollapudi S, Pahl MV, Vaziri ND. Naive and central memory T-cell lymphopenia in end-stage renal disease. Kidney Int. 2006;70:371–6.
11. Litjens NH, Huisman M, van den Dorpel M, Betjes MG. Impaired immune responses and antigen-specific memory CD4+ T cells in hemodialysis patients. J Am Soc Nephrol. 2008;19:1483–90.
12. Betjes MG. Immune cell dysfunction and inflammation in end-stage renal disease. Nat Rev Nephrol. 2013;9:255–65. This review is an in-depth analysis of the current knowledge on the role of inflammation, oxidative stress and dysfunction of both the adaptive and innate immune response in ESRD patients.
13. Pahl MV, Gollapudi S, Sepassi L, Gollapudi P, Elahimehr R, Vaziri ND. Effect of end-stage renal disease on B-lymphocyte subpopulations, IL-7, BAFF and BAFF receptor expression. Nephrol Dial Transplant. 2010;25:205–12.
14. Lim WH, Kireta S, Thomson AW, Russ GR, Coates PT. Renal transplantation reverses functional deficiencies in circulating dendritic cell subsets in chronic renal failure patients. Transplantation. 2006;81:160–8.
15. Hesselink DA, Betjes MG, Verkade MA, Athanassopoulos P, Baan CC, Weimar W. The effects of chronic kidney disease and renal replacement therapy on circulating dendritic cells. Nephrol Dial Transplant. 2005;20:1868–73.
16. Agrawal S, Gollapudi P, Elahimehr R, Pahl MV, Vaziri ND. Effects of end-stage renal disease and haemodialysis on dendritic cell subsets and basal and LPS-stimulated cytokine production. Nephrol Dial Transplant. 2010;25:737–46.
17. Verkade MA, van Druningen CJ, Vaessen LM, Hesselink DA, Weimar W, Betjes MG. Functional impairment of monocyte-derived dendritic cells in patients with severe chronic kidney disease. Nephrol Dial Transplant. 2007;22:128–38.
18. Witko-Sarsat V, Friedlander M, Nguyen Khoa T, et al. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol. 1998;161:2524–32.
19. Vaziri ND. Oxidative stress in uremia: nature, mechanisms, and potential consequences. Semin Nephrol. 2004;24:469–73.
20. Akar H, Akar GC, Carrero JJ, Stenvinkel P, Lindholm B. Systemic consequences of poor oral health in chronic kidney disease patients. Clin J Am Soc Nephrol. 2011;6:218–26.
21. Anders HJ, Andersen K, Stecher B. The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease. Kidney Int. 2013;83:1010–6. This article describes a novel source of chronic inflammation, the leaky gut in uremic patients. The possible relation with abnormal immunity in these patients is discussed.
22. Betjes MG, de Wit EE, Weimar W, Litjens NH. Circulating pro-inflammatory CD4posCD28null T cells are independently associated with cardiovascular disease in ESRD patients. Nephrol Dial Transplant. 2010;25:3640–6.
23. McKay D, Jameson J. Kidney transplantation and the ageing immune system. Nat Rev Nephrol. 2012;8:700–8. This review describes the various aspects of the ageing immune system and the consequences thereof for immune suppressive therapy after kidney transplantation.
24. den Braber I, Mugwagwa T, Vrisekoop N, et al. Maintenance of peripheral naive T cells is sustained by thymus output in mice but not humans. Immunity. 2012;36:288–97. This article gives a thorough analysis of findings in mice and humans on the maintenance of peripheral naïve T cells. Based on elaborated cell labeling techniques and modelling it is clear that findings from mice studies cannot be extrapolated to explain T cell homeostasis in humans and vice versa.
25. Westera L, Drylewicz J, den Braber I, et al. Closing the gap between T-cell life span estimates from stable isotope-labeling studies in mice and humans. Blood. 2013;122:2205–12.
26. Kohler S, Thiel A. Life after the thymus: CD31+ and CD31- human naive CD4+ T-cell subsets. Blood. 2009;113:769–74.
27. Meijers RW, Litjens NH, de Wit EA, et al. Uremia causes premature ageing of the T cell compartment in end-stage renal disease patients. Immun Ageing. 2012;9:19.
28. Betjes MG, Meijers RW, de Wit LE, Litjens NH. A killer on the road: circulating CD4(+)CD28null T cells as cardiovascular risk factor in ESRD patients. J Nephrol. 2012;25:183–91.
29. Betjes MG, Huisman M, Weimar W, Litjens NH. Expansion of cytolytic CD4 + CD28-T cells in end-stage renal disease. Kidney Int. 2008;74:760–7.
30. Betjes MG, Litjens NH, Zietse R. Seropositivity for cytomegalovirus in patients with end-stage renal disease is strongly associated with atherosclerotic disease. Nephrol Dial Transplant. 2007;22:3298–303.
31. Courivaud C, Bamoulid J, Chalopin JM, et al. Cytomegalovirus exposure and cardiovascular disease in kidney transplant recipients. J Infect Dis. 2013;207:1569–75. The authors show that cytomegalovirus infections in recently transplanted patients induces an increased risk for a vascular event. This finding supports the concept of the pro-atherogenic role of CMV infection in kidney transplantation patients.
32. van de Berg PJ, Heutinck KM, Raabe R, et al. Human cytomegalovirus induces systemic immune activation characterized by a type 1 cytokine signature. J Infect Dis. 2010;202:690–9.
33. van de Berg PJ, Griffiths SJ, Yong SL, et al. Cytomegalovirus infection reduces telomere length of the circulating T cell pool. J Immunol. 2010;184:3417–23.
34. Zawada AM, Rogacev KS, Hummel B, et al. SuperTAG Methylation-Specific Digital Karyotyping (SMSDK) Reveals Uremia Induced Epigenetic Dysregulation of Atherosclerosis-Related Genes. Circ Cardiovasc Genet. 2012;5:611–20.
35. Scherberich JE, Nockher WA. CD14++ monocytes, CD14+/CD16+ subset and soluble CD14 as biological markers of inflammatory systemic diseases and monitoring immunosuppressive therapy. Clin Chem Lab Med. 1999;37:209–13.
36. Meijers RW, Litjens NH, de Wit EA, Langerak AW, Baan CC, Betjes MG. Uremia-associated immunological ageing is stably imprinted in the T-cell system and not reversed by kidney transplantation. Transpl Int 2014. This article describes that premature immunological ageing is not reversed in stable kidney transplant patients, irrespective of their age and renal allograft function. This is compatible with the concept of epigenetic imprinting.
37. Betjes MG, Weimar W, Litjens NH. Circulating CD4(+)CD28null T Cells May Increase the Risk of an Atherosclerotic Vascular Event Shortly after Kidney Transplantation. J Transplant. 2013;2013:841430.
38. Betjes MG, Meijers RW, de Wit EA, Weimar W, Litjens NH. Terminally differentiated CD8+ Temra cells are associated with the risk for acute kidney allograft rejection. Transplantation. 2012;94:63–9.
39. Sportes C, Hakim FT, Memon SA, et al. Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets. J Exp Med. 2008;205:1701–14.
40. Ruiz S, Pergola PE, Zager RA, Vaziri ND. Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease. Kidney Int. 2013;83:1029–41.